AB120523
GR 127935 hydrochloride, 5-HT1B/1D receptor antagonist
Be the first to review this product! Submit a review
|
(2 Publications)
MW 534.06 g/mol, Purity >97%. Potent and selective 5-HT1B/1D receptor antagonist (pKi = 8.5 for both 5-HT1D in rat and 5-HT1D in guinea pig). 100-fold selectivity over 5-HT1A, 5-HT1E, and 5-HT2C. Displays centrally mediated effects upon systemic administration.
1 Images
- Chemical Structure
Lab
Chemical Structure - GR 127935 hydrochloride, 5-HT1B/1D receptor antagonist (AB120523)
2D chemical structure image of ab120523, GR 127935 hydrochloride, 5-HT1B/1D receptor antagonist
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 39:110795 PubMed35545050
2022
Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens.
Applications
Unspecified application
Species
Unspecified reactive species
Dennis A Burke,Veronica A Alvarez
Scientific reports 7:13609 PubMed29051549
2017
Chronic antidepressant potentiates spontaneous activity of dorsal raphe serotonergic neurons by decreasing GABA receptor-mediated inhibition of L-type calcium channels.
Applications
Unspecified application
Species
Unspecified reactive species
Nozomi Asaoka,Naoya Nishitani,Haruko Kinoshita,Hiroyuki Kawai,Norihiro Shibui,Kazuki Nagayasu,Hisashi Shirakawa,Takayuki Nakagawa,Shuji Kaneko
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com